Funder
Jiangsu Higher Education Institutions
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference12 articles.
1. Trelagliptin: first global approval;McKeage;Drugs,2015
2. First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus;Kaku;Expert Opin. Pharmacol.,2015
3. Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3 non-inferiority study;Inagaki;Lancet Diabetes Endocrinol.,2015
4. T. Klein, M. Mark, H. Niessen, L. Thomas, DPP-IV inbibitors foruse in the treatment of nafld, WO Patent 2009147125 A1 (2009).
5. M.L. Bao, M. You, X.F. Zhao, A method for the quantification of related substances in Trelagliptin succinate and its preparation, CN Patent 104237421 A (2014).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献